RECRUITINGOBSERVATIONAL
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia
About This Trial
SLE disease in Saudi Arabia is yet not well defined especially in a population with high consanguinity and high inbreeding coefficient . Up until now, there has been no prospective cohort study for SLE patients in Saudi Arabia. As a result, current published literature is focused on retrospective chart reviews which are subjected to many forms of bias. so the investigator proposed this prospective registry which will follow open cohort study design aiming to provide better understanding of disease presentation, course and outcomes especially if complemented by detailed immunological, molecular, genetic and microbiome data.
Who May Be Eligible (Plain English)
Who May Qualify:
1. Adult patients defined as age greater than 18 years old.
2. Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria).
3. No restriction on time of diagnosis.
Who Should NOT Join This Trial:
- Patients who don't fulfil classification criteria mentioned above.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. Adult patients defined as age greater than 18 years old.
2. Patients should fulfil one of the following classification criteria for SLE (ACR, SLICC or ACR/EULAR criteria).
3. No restriction on time of diagnosis.
Exclusion Criteria:
* Patients who don't fulfil classification criteria mentioned above.
Locations (1)
king Saud University medical city
Riyadh, Central Province, Saudi Arabia